article thumbnail

This Common Artificial Sweetener Can Break Down DNA, Scientists Warn

AuroBlog - Aurous Healthcare Clinical Trials blog

The artificial sweetener sucralose (marketed as Splenda) is widely used and found in products like diet soda and chewing gum. According to a new study, it’s also capable of damaging the DNA material inside our cells.

DNA 245
article thumbnail

FDA withdraws preterm birth drug’s approval, denying maker’s request for delay

Bio Pharma Dive

Agency Commissioner Robert Califf and Chief Scientist Namandjé Bumpus determined there was “no justification” for keeping Covis Pharma’s controversial treatment Makena on the market.

Scientist 205
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Field Application Scientist Jobs: Everything You Need to Know

XTalks

A field application scientist is a valuable member of any life science company due to their direct interaction with customers. Field application scientists help laboratory groups successfully install and apply the newest scientific supplies, equipment, instruments and software. Field Scientist Job Description.

article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and speed up time to market whilst improving outcomes, and most recognise that incorporating automation and AI into their workflows will be game-changing. Lead the way with a scientist-centric mindset. Translating physical into digital.

article thumbnail

Leading commercial dose companies in contract marketing

Pharmaceutical Technology

The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contract manufacturing market, which has fuelled contract commercial dose manufacturing and marketing. Discover the leading commercial dose companies in contract marketing.

Marketing 100
article thumbnail

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

Scientists now use cutting-edge techniques, including biological therapies that target specific immune system components and precision medicine approaches that personalize treatment plans based on a patient’s genetic profile.

Research 147
article thumbnail

Gilead’s Sunlenca receives EC approval to treat HIV

Pharmaceutical Technology

Gilead Sciences has obtained the European Commission (EC) marketing authorisation for Sunlenca (lenacapavir) injection and tablets to treat human immunodeficiency virus (HIV) infection. With the approval from the EC, the treatment will be made available in all 27 European Union member states as well as Liechtenstein, Norway and Iceland.